Clinical Trials · NCT02359500
68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)
- Phase
- Phase 1
- Recruitment status
- Terminated
- Sponsor
- Lale Kostakoglu
- Enrollment
- 71
- Start date
- Dec 2014
- Locations
- 1 site, United States
- Primary endpoint
- Change in size of lesion